ALPHATEC HOLDINGS, INC. Operating Lease, Payments
ALPHATEC HOLDINGS, INC. (ATEC) reported Operating Lease, Payments of $1.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. operating lease, payments for the quarter ending 2026-06-30 was $1.88M, a 2.01% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, payments for the quarter ending 2026-03-31 was $1.83M, a 2.98% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, payments for the quarter ending 2025-12-31 was $1.81M, a 24.72% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, payments for the quarter ending 2025-09-30 was $1.84M, a 4.02% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, payments for fiscal 2025 was $7.31M, a 16.06% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. operating lease, payments for fiscal 2024 was $6.30M, a 22.97% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. operating lease, payments for fiscal 2023 was $5.12M, a 16.13% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. operating lease, payments for fiscal 2022 was $4.41M, a 145.63% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-04 | $3.73M 10-Q · filed 2026-08-04 | $5.52M derived: sum of 3 quarters · filed 2026-08-04 | $7.35M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $1.83M 10-Q · filed 2026-05-05 | $3.64M derived: sum of 2 quarters · filed 2026-05-05 | $5.48M derived: sum of 3 quarters · filed 2026-05-05 | $7.32M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.64M derived: sum of 2 quarters · filed 2026-02-24 | $5.48M derived: sum of 3 quarters · filed 2026-08-04 | $7.31M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $1.84M 10-Q · filed 2025-10-30 | $3.68M derived: sum of 2 quarters · filed 2026-08-04 | $5.50M 10-Q · filed 2025-10-30 | $6.91M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $1.84M 10-Q · filed 2026-08-04 | $3.67M 10-Q · filed 2026-08-04 | $5.07M derived: sum of 3 quarters · filed 2026-08-04 | $6.83M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $1.78M 10-Q · filed 2026-05-05 | $3.23M derived: sum of 2 quarters · filed 2026-05-05 | $5.00M derived: sum of 3 quarters · filed 2026-05-05 | $6.76M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.21M derived: sum of 2 quarters · filed 2026-02-24 | $4.98M derived: sum of 3 quarters · filed 2026-02-24 | $6.30M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $1.77M 10-Q · filed 2025-10-30 | $3.53M derived: sum of 2 quarters · filed 2025-10-30 | $4.85M 10-Q · filed 2025-10-30 | $6.30M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $1.76M 10-Q · filed 2025-07-31 | $3.19M 10-Q · filed 2025-07-31 | $4.54M derived: sum of 3 quarters · filed 2026-02-24 | $5.85M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $1.42M 10-Q · filed 2025-05-01 | $2.77M derived: sum of 2 quarters · filed 2026-02-24 | $4.09M derived: sum of 3 quarters · filed 2026-02-24 | $5.35M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.67M derived: sum of 2 quarters · filed 2026-02-24 | $3.93M derived: sum of 3 quarters · filed 2026-02-24 | $5.12M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $1.32M 10-Q · filed 2024-10-30 | $2.58M derived: sum of 2 quarters · filed 2024-10-30 | $3.77M 10-Q · filed 2024-10-30 | $8.17M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $1.26M 10-Q · filed 2024-07-31 | $2.45M 10-Q · filed 2024-07-31 | $6.86M derived: sum of 3 quarters · filed 2025-02-26 | $7.89M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $4.37M 10-Q · filed 2024-05-07 | $5.59M derived: sum of 2 quarters · filed 2025-02-26 | $6.62M derived: sum of 3 quarters · filed 2025-02-26 | $7.75M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.26M derived: sum of 2 quarters · filed 2025-02-26 | $3.39M derived: sum of 3 quarters · filed 2025-02-26 | $4.41M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $1.03M 10-Q · filed 2023-11-06 | $2.16M derived: sum of 2 quarters · filed 2023-11-06 | $3.18M 10-Q · filed 2023-11-06 | $3.71M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | $1.13M 10-Q · filed 2023-08-03 | $2.15M 10-Q · filed 2023-08-03 | $2.68M derived: sum of 3 quarters · filed 2024-02-27 | $3.07M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $1.02M 10-Q · filed 2023-05-04 | $1.55M derived: sum of 2 quarters · filed 2024-02-27 | $1.94M derived: sum of 3 quarters · filed 2024-02-27 | $2.44M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $920.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.42M derived: sum of 3 quarters · filed 2024-02-27 | $1.79M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $393.00K 10-Q · filed 2022-11-03 | $888.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.27M 10-Q · filed 2022-11-03 | $1.55M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $495.00K 10-Q · filed 2022-08-04 | $875.00K 10-Q · filed 2022-08-04 | $1.16M derived: sum of 3 quarters · filed 2023-02-28 | $1.53M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $380.00K 10-Q · filed 2022-05-05 | $400.00K 10-Q · filed 2021-05-06 | $667.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.04M derived: sum of 3 quarters · filed 2023-02-28 | $1.41M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $660.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.03M derived: sum of 3 quarters · filed 2023-02-28 | $1.40M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $373.00K 10-Q · filed 2021-11-04 | $400.00K 10-Q · filed 2020-11-05 | $745.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.11M 10-Q · filed 2021-11-04 | $1.10M 10-Q · filed 2020-11-05 | $1.54M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $372.00K 10-Q · filed 2021-08-03 | $400.00K 10-Q · filed 2020-08-06 | $741.00K 10-Q · filed 2021-08-03 | $700.00K 10-Q · filed 2020-08-06 | $1.17M derived: sum of 3 quarters · filed 2021-08-03 | $1.57M derived: sum of 4 quarters · filed 2021-08-03 | |
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-06 | $800.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.20M derived: sum of 3 quarters · filed 2021-05-06 | $1.60M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $800.00K derived: sum of 2 quarters · filed 2021-03-05 | $1.20M derived: sum of 3 quarters · filed 2021-03-05 | $1.40M 10-K · filed 2021-03-05 | |||
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-05 | $800.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.00M 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $400.00K 10-Q · filed 2020-08-06 | $300.00K 10-Q · filed 2019-07-26 | $700.00K 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $300.00K 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | $1.40M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |